深圳市海王生物工程股份有限公司2025年度股东大会决议详解
一、会议召开及重要提示
深圳市海王生物工程股份有限公司（证券简称：ST海王，代码：000078）于2026年6月5日召开了2025年度股东大会。本次会议采取现场与网络投票相结合方式，出席股东共1211人，代表股份1,257,933,406股，占公司表决权股份总数的47.81%。其中现场投票6人，代表股份1,225,446,226股，网络投票1205人，代表股份32,487,180股。
会议期间无否决或变更提案。控股股东深圳海王集团股份有限公司于5月22日提议增加临时提案，并被董事局同意提交至年度股东会审议，包括《关于转让控股子公司股权被动形成对外财务资助的议案》和《关于担保延续构成对外担保的议案》。
二、股东投票及议案审议结果
- 董事局工作报告、利润分配预案等常规议案： 多项常规议案如《2025年度董事局工作报告》、《2025年度利润分配预案》、《关于公司未弥补亏损超过实收股本总额三分之一的议案》、《关于续聘2026年度审计机构的议案》等均以高票通过，赞成率均在98%以上。中小股东赞成率约为67%，反对率约为30%，弃权率在1-2%之间。
- 董事、高管薪酬及薪酬管理制度： 董事、高级管理人员薪酬方案及薪酬管理制度的议案均通过，部分关联股东回避表决，薪酬方案实际有效表决股数为1,256,602,313股。中小股东赞成率为66.5%，反对率为31.7%，弃权率为1.8%。
- 2026年度日常关联交易预计： 关联股东（深圳海王集团及张锋）共计持有1,217,776,221股回避表决，本议案实际有效表决股数为40,157,185股。中小股东赞成率为67.8%，反对率30.34%，弃权率1.83%。
- 对外财务资助及担保事项： 《关于追认对外财务资助及担保事项的议案》通过，但中小股东反对率高达49.7%，赞成率48.4%，弃权率1.8%。显示对外财务资助及担保事项较为敏感，可能引发投资者关注。
- 控股子公司股权转让及对外担保： 《关于转让控股子公司股权被动形成对外财务资助的议案》和《关于担保延续构成对外担保的议案》均通过，赞成率98%以上。中小股东赞成率约67%，反对率约31%，弃权1.6%。
三、与股价相关的潜在敏感事项
- 对外财务资助及担保事项： 此议案中小股东反对率接近50%，显示公司对外财务资助与担保事项存在较大争议，可能影响公司财务稳健性和股价波动，需投资者重点关注。
- 控股子公司股权转让： 股权转让被动形成对外财务资助，可能影响公司资产结构及未来现金流，亦为股价敏感事项。
- 关联交易与薪酬管理： 大量关联股东回避表决，显示公司关联交易及薪酬制度调整，可能影响公司治理结构及未来业绩表现。
四、律师见证与决议有效性
北京德恒（深圳）律师事务所出具法律意见，认为本次会议召集、召开程序合法，会议决议有效。
五、投资者须知与风险提示
- 公司对外财务资助及担保事项争议较大，可能影响财务健康及股价。
- 控股子公司股权转让与关联交易事项需持续关注，可能影响公司资产结构与治理。
- 薪酬管理及审计机构续聘等议案均高票通过，显示公司治理稳定。
免责声明
本新闻分析仅供参考，不构成任何投资建议。请投资者结合自身风险承受能力，审慎决策。
Detailed Report on Shenzhen Haiwang Bioengineering Co., Ltd. 2025 AGM Resolutions
1. Meeting Overview & Key Highlights
Shenzhen Haiwang Bioengineering Co., Ltd. (ST Haiwang, code: 000078) held its 2025 annual shareholders’ meeting on June 5, 2026. The meeting combined on-site and online voting, with 1,211 shareholders attending and representing 1,257,933,406 shares (47.81% of total voting shares). Of these, 6 attended on-site, representing 1,225,446,226 shares; 1,205 voted online, representing 32,487,180 shares.
No proposals were rejected or amended. The controlling shareholder, Shenzhen Haiwang Group Co., Ltd., proposed two additional motions: “Passive External Financial Support from Transfer of Subsidiary Equity” and “Extension of External Guarantees”, both of which were accepted for AGM review.
2. Voting Results & Resolution Details
- Routine Resolutions: Standard items such as the Board’s work report, profit distribution plan, and loss coverage were all approved with over 98% support. Minority shareholders supported at rates around 67%, with about 30% opposition and 1-2% abstentions.
- Executive Compensation & Salary Management: Compensation and salary management for directors and senior executives were approved. Some related shareholders abstained. Minority shareholder support was 66.5%, opposition 31.7%, abstention 1.8%.
- 2026 Related Transactions Estimate: Related shareholders abstained from voting (over 1.2 billion shares), leaving 40,157,185 shares for the actual vote. Minority shareholders supported at 67.8%, opposed at 30.34%, abstained at 1.83%.
- External Financial Support & Guarantees: The motion to ratify external financial support and guarantees was approved, but minority shareholder opposition was high (49.7%), indicating controversy and potential impact on financial stability and share price.
- Subsidiary Equity Transfer & Guarantee Extensions: Motions on subsidiary equity transfer and guarantee extensions passed with over 98% support. Minority shareholders showed 67% support, 31% opposition, and 1.6% abstention.
3. Price Sensitive & Shareholder-Relevant Issues
- External Financial Support & Guarantees: Nearly 50% opposition from minority shareholders signals controversy and potential impact on financial health and share price. Investors should monitor these developments closely.
- Subsidiary Equity Transfer: Passive external financial support from equity transfer may alter asset structure and future cash flow, a price-sensitive issue.
- Related Transactions & Salary Management: Large-scale related shareholder abstentions indicate changes in related transactions and salary policies, potentially affecting governance and performance.
4. Legal Review & Validity
Beijing Deheng (Shenzhen) Law Firm confirmed the legality of the meeting and its resolutions.
5. Investor Notes & Risks
- Controversy over external financial support and guarantees could affect financial health and share price.
- Subsidiary equity transfer and related transactions may impact asset structure and governance.
- Routine resolutions show stable governance.
Disclaimer
This article is for information only and does not constitute investment advice. Investors should make decisions based on their own risk tolerance.
